mirtazapine has been researched along with Diffuse Myofascial Pain Syndrome in 6 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of mirtazapine in Japanese patients with fibromyalgia (FM), a parallel-group, randomized, double-blind, placebo-controlled phase IIa study was conducted at 57 sites between November 2012 and February 2014." | 9.22 | Efficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression: a randomized, double-blind, placebo-controlled phase IIa study in Japan. ( Miki, K; Murakami, M; Oka, H; Onozawa, K; Osada, K; Yoshida, S, 2016) |
| " Eighteen patients had at least moderate depression before mirtazapine treatment and 8 patients presented mild depressive symptoms." | 9.11 | Open trial of mirtazapine in patients with fibromyalgia. ( Lezanska-Szpera, M; Rybakowski, JK; Samborski, W, 2004) |
| "To assess the efficacy, tolerability and safety of the tetracyclic antidepressant, mirtazapine, compared with placebo or other active drug(s) in the treatment of fibromyalgia in adults." | 8.98 | Mirtazapine for fibromyalgia in adults. ( Bernardy, K; Derry, S; Häuser, W; Moore, RA; Welsch, P, 2018) |
| "On the background of a restricted armamentarium of drugs available for the management of fibromyalgia (FM), we aimed to compare the real-world effectiveness of two serotonin-norepinephrine reuptake inhibitors (SNRIs), mirtazapine (MTZ) and duloxetine (DLX) in FM." | 8.12 | Effectiveness and adverse effects of the use of mirtazapine as compared to duloxetine for fibromyalgia: real-life data from a retrospective cohort. ( Ahmed, S; Basu, A; Mehta, P, 2022) |
| " Study durations ranged from 6 to 13 weeks and studies used varying dosing strategies for mirtazapine." | 6.58 | The role of mirtazapine in patients with fibromyalgia: a systematic review. ( Brown, JN; Ottman, AA; Warner, CB, 2018) |
| "To evaluate the efficacy and safety of mirtazapine in Japanese patients with fibromyalgia (FM), a parallel-group, randomized, double-blind, placebo-controlled phase IIa study was conducted at 57 sites between November 2012 and February 2014." | 5.22 | Efficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression: a randomized, double-blind, placebo-controlled phase IIa study in Japan. ( Miki, K; Murakami, M; Oka, H; Onozawa, K; Osada, K; Yoshida, S, 2016) |
| " Eighteen patients had at least moderate depression before mirtazapine treatment and 8 patients presented mild depressive symptoms." | 5.11 | Open trial of mirtazapine in patients with fibromyalgia. ( Lezanska-Szpera, M; Rybakowski, JK; Samborski, W, 2004) |
| "To assess the efficacy, tolerability and safety of the tetracyclic antidepressant, mirtazapine, compared with placebo or other active drug(s) in the treatment of fibromyalgia in adults." | 4.98 | Mirtazapine for fibromyalgia in adults. ( Bernardy, K; Derry, S; Häuser, W; Moore, RA; Welsch, P, 2018) |
| "On the background of a restricted armamentarium of drugs available for the management of fibromyalgia (FM), we aimed to compare the real-world effectiveness of two serotonin-norepinephrine reuptake inhibitors (SNRIs), mirtazapine (MTZ) and duloxetine (DLX) in FM." | 4.12 | Effectiveness and adverse effects of the use of mirtazapine as compared to duloxetine for fibromyalgia: real-life data from a retrospective cohort. ( Ahmed, S; Basu, A; Mehta, P, 2022) |
| " Study durations ranged from 6 to 13 weeks and studies used varying dosing strategies for mirtazapine." | 2.58 | The role of mirtazapine in patients with fibromyalgia: a systematic review. ( Brown, JN; Ottman, AA; Warner, CB, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Mehta, P | 1 |
| Basu, A | 1 |
| Ahmed, S | 1 |
| Ottman, AA | 1 |
| Warner, CB | 1 |
| Brown, JN | 1 |
| Welsch, P | 1 |
| Bernardy, K | 1 |
| Derry, S | 1 |
| Moore, RA | 1 |
| Häuser, W | 1 |
| Miki, K | 1 |
| Murakami, M | 1 |
| Oka, H | 1 |
| Onozawa, K | 1 |
| Yoshida, S | 1 |
| Osada, K | 1 |
| Samborski, W | 2 |
| Lezanska-Szpera, M | 2 |
| Rybakowski, JK | 2 |
2 reviews available for mirtazapine and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
The role of mirtazapine in patients with fibromyalgia: a systematic review.
Topics: Fibromyalgia; Health Status; Humans; Mirtazapine; Neurotransmitter Agents; Pain Threshold; Quality o | 2018 |
Mirtazapine for fibromyalgia in adults.
Topics: Adult; Antidepressive Agents, Tricyclic; Fibromyalgia; Humans; Mianserin; Mirtazapine; Randomized Co | 2018 |
3 trials available for mirtazapine and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Efficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression: a randomized, double-blind, placebo-controlled phase IIa study in Japan.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Tricyclic; Depression; Double-Blind Method; Fema | 2016 |
Open trial of mirtazapine in patients with fibromyalgia.
Topics: Adrenergic alpha-Antagonists; Adult; Depression; Drug Administration Schedule; Female; Fibromyalgia; | 2004 |
Effects of antidepressant mirtazapine on fibromyalgia symptoms.
Topics: Adult; Antidepressive Agents, Tricyclic; Female; Fibromyalgia; Humans; Male; Mianserin; Middle Aged; | 2004 |
1 other study available for mirtazapine and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Effectiveness and adverse effects of the use of mirtazapine as compared to duloxetine for fibromyalgia: real-life data from a retrospective cohort.
Topics: Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Male; Middle Aged; Mirtazapine; Retrospectiv | 2022 |